Log in

Blonder Tongue Labs Stock Forecast, Price & News

-0.18 (-12.41 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $1.27
50-Day Range N/A
52-Week Range
Now: $1.27
Volume191,443 shs
Average Volume744,325 shs
Market Capitalization$12.40 million
P/E RatioN/A
Dividend YieldN/A
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers digital video headend products comprising high definition and SD, MPEG-2, and MPEG-4/H.264 encoders, as well as quadrature phase shift key to quadrature amplitude modulation (QAM) transcoders; digital QAM multiplexers; ATSC/QAM-IP transcoders; and EdgeQAM devices. The company provides its digital video headend products for use by system operators for acquisition, processing, compression, encoding, and management of digital videos. In addition, the company offers analog video headend products, including pre-fabricated headends to accommodate legacy analog television systems, modulators, demodulators, and processors for use by system operators for signal acquisition, processing, and manipulation to create an analog channel lineup for further transmission. Further, it provides hybrid-fiber coax distribution products comprising broadband amplifiers, directional taps, splitters, and wall outlets for coax distribution and fiber optic transmitters, receivers, and couplers. Additionally, the company offers data products to deliver data, video, and voice-over-coaxial in hospitality, multiple dwelling unit, and college campus locations; and test instruments, contract manufacturing and technical services, reception products, and miscellaneous products and services. It serves television broadcasters, cable system operators, and lodging/hospitality video and high-speed Internet system operators, as well as commercial/institutional/enterprise system operators, including educational campus environments, correctional facilities, short and long term health service environments, sports stadiums, and airport terminals through its sales force and stocking distributors. The company was founded in 1950 and is headquartered in Old Bridge, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars

Industry, Sector and Symbol

Industry Communication Equipment



Sales & Book Value

Annual SalesN/A



Market Cap$12.40 million
Next Earnings Date11/13/2020 (Confirmed)
OptionableNot Optionable
-0.18 (-12.41 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BDR News and Ratings via Email

Sign-up to receive the latest news and ratings for BDR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Blonder Tongue Labs (NYSEAMERICAN:BDR) Frequently Asked Questions

When is Blonder Tongue Labs' next earnings date?

Blonder Tongue Labs is scheduled to release its next quarterly earnings announcement on Friday, November 13th 2020.
View our earnings forecast for Blonder Tongue Labs

How can I listen to Blonder Tongue Labs' earnings call?

Blonder Tongue Labs will be holding an earnings conference call on Friday, November 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Blonder Tongue Labs' earnings last quarter?

Blonder Tongue Labs, Inc. (NYSEAMERICAN:BDR) announced its quarterly earnings data on Friday, August, 7th. The technology company reported ($0.12) earnings per share for the quarter. The technology company earned $3.83 million during the quarter.
View Blonder Tongue Labs' earnings history

Are investors shorting Blonder Tongue Labs?

Blonder Tongue Labs saw a increase in short interest in October. As of October 15th, there was short interest totaling 994,500 shares, an increase of 6,001.2% from the September 30th total of 16,300 shares. Based on an average trading volume of 2,310,000 shares, the short-interest ratio is currently 0.4 days. Currently, 30.4% of the company's stock are sold short.
View Blonder Tongue Labs' Short Interest

Who are some of Blonder Tongue Labs' key competitors?

What other stocks do shareholders of Blonder Tongue Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blonder Tongue Labs investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Co-Diagnostics (CODX), Aduro Biotech (ADRO), Ibio (IBIO), Aethlon Medical (AEMD), Altimmune (ALT), Amarin (AMRN), Actinium Pharmaceuticals (ATNM) and Biocept (BIOC).

Who are Blonder Tongue Labs' key executives?

Blonder Tongue Labs' management team includes the following people:
  • Mr. Robert J. Pallé Jr., CEO, Pres & Director (Age 73)
  • Mr. Jeffrey W. Smith, VP of Sales & Marketing (Age 55)
  • Mr. Eric S. Skolnik, Sr. VP, CFO, Treasurer & Sec. (Age 54)
  • Mr. Edward Rowland Grauch, Exec. VP & COO (Age 53)
  • Mr. Ronald V. Alterio, VP of Engineering & CTO (Age 49)

What is Blonder Tongue Labs' stock symbol?

Blonder Tongue Labs trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BDR."

How do I buy shares of Blonder Tongue Labs?

Shares of BDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Blonder Tongue Labs' stock price today?

One share of BDR stock can currently be purchased for approximately $1.27.

How big of a company is Blonder Tongue Labs?

Blonder Tongue Labs has a market capitalization of $12.40 million. Blonder Tongue Labs employs 117 workers across the globe.

What is Blonder Tongue Labs' official website?

The official website for Blonder Tongue Labs is www.blondertongue.com.

How can I contact Blonder Tongue Labs?

Blonder Tongue Labs' mailing address is 1 Jake Brown Rd PO Box 1000, OLD BRIDGE, NJ 08857-1000, United States. The technology company can be reached via phone at +1-908-6794000.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.